Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1991-6-26
|
pubmed:abstractText |
Good antipyretic response was obtained when naproxen was given at 600 mg/day for about one week to patients who developed fever after transcatheter arterial embolization (TAE). Fever recurred in several patients, but subsided again when naproxen was given at 300 mg/day. No patients developed gastric mucosal lesions of clinical concern that seemed to be related to naproxen.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0288-2043
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
227-9
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:1965557-Aged,
pubmed-meshheading:1965557-Carcinoma, Hepatocellular,
pubmed-meshheading:1965557-Embolization, Therapeutic,
pubmed-meshheading:1965557-Fever,
pubmed-meshheading:1965557-Humans,
pubmed-meshheading:1965557-Liver Neoplasms,
pubmed-meshheading:1965557-Male,
pubmed-meshheading:1965557-Naproxen
|
pubmed:articleTitle |
Study of response to naproxen in patients with hepatocellular carcinoma who developed fever following transcatheter arterial embolization.
|
pubmed:affiliation |
Department of Internal Medicine, Nishiyodo Hospital, Japan.
|
pubmed:publicationType |
Journal Article,
Case Reports
|